BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 19235775)

  • 21. Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer.
    Hu XT; Zhang FB; Fan YC; Shu XS; Wong AH; Zhou W; Shi QL; Tang HM; Fu L; Guan XY; Rha SY; Tao Q; He C
    Oncogene; 2009 Jul; 28(26):2466-75. PubMed ID: 19448674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular basis of breast cancer.
    Al-Mansouri LJ; Alokail MS
    Saudi Med J; 2006 Jan; 27(1):9-16. PubMed ID: 16432586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosome 16 tumor-suppressor genes in breast cancer.
    Rakha EA; Green AR; Powe DG; Roylance R; Ellis IO
    Genes Chromosomes Cancer; 2006 Jun; 45(6):527-35. PubMed ID: 16518845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospects for cancer genetics.
    Weinberg RA
    Cancer Surv; 1995; 25():3-12. PubMed ID: 8718510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity.
    Deblois G; Hall JA; Perry MC; Laganière J; Ghahremani M; Park M; Hallett M; Giguère V
    Cancer Res; 2009 Aug; 69(15):6149-57. PubMed ID: 19622763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular profiling in the age of cancer genomics.
    Lin J; Li M
    Expert Rev Mol Diagn; 2008 May; 8(3):263-76. PubMed ID: 18598106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
    Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
    Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of interactive networks of gene expression associated with osteosarcoma oncogenesis by integrated molecular profiling.
    Sadikovic B; Yoshimoto M; Chilton-MacNeill S; Thorner P; Squire JA; Zielenska M
    Hum Mol Genet; 2009 Jun; 18(11):1962-75. PubMed ID: 19286668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An investigation of microRNAs mapping to breast cancer related genomic gain and loss regions.
    Selcuklu SD; Yakicier MC; Erson AE
    Cancer Genet Cytogenet; 2009 Feb; 189(1):15-23. PubMed ID: 19167607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA involvement in the pathogenesis and management of breast cancer.
    Khoshnaw SM; Green AR; Powe DG; Ellis IO
    J Clin Pathol; 2009 May; 62(5):422-8. PubMed ID: 19398594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic instability in the breast microenvironment? A critical evaluation of the evidence.
    Holliday C; Rummel S; Hooke JA; Shriver CD; Ellsworth DL; Ellsworth RE
    Expert Rev Mol Diagn; 2009 Oct; 9(7):667-78. PubMed ID: 19817552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer and genomics.
    Futreal PA; Kasprzyk A; Birney E; Mullikin JC; Wooster R; Stratton MR
    Nature; 2001 Feb; 409(6822):850-2. PubMed ID: 11237008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Breast cancer and oncogenes].
    Toyoshima K
    Gan No Rinsho; 1989 May; Spec No():199-203. PubMed ID: 2574753
    [No Abstract]   [Full Text] [Related]  

  • 34. [Molecular cancer biology--from research to clinical practice].
    Nielsen FC
    Ugeskr Laeger; 2003 Feb; 165(9):897-900. PubMed ID: 12661511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Oncogene and tumor suppressor gene].
    Nagai H; Harada H; Emi M
    Nihon Rinsho; 2000 Apr; 58 Suppl():25-9. PubMed ID: 11025969
    [No Abstract]   [Full Text] [Related]  

  • 36. [Molecular indicators of neoplasia in clinical diagnostics].
    Gawron K; Wiczkowski A; Adamek B
    Pol Merkur Lekarski; 2005 Mar; 18(105):323-8. PubMed ID: 15997644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular genetics of human breast cancer.
    McKenzie K; Sukumar S
    Prog Clin Biol Res; 1996; 394():183-209. PubMed ID: 8778797
    [No Abstract]   [Full Text] [Related]  

  • 38. New molecular classifications of breast cancer.
    Cianfrocca M; Gradishar W
    CA Cancer J Clin; 2009; 59(5):303-13. PubMed ID: 19729680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel integrative methods for gene discovery associated with head and neck squamous cell carcinoma development.
    Smith IM; Mithani SK; Liu C; Chang SS; Begum S; Dhara M; Westra W; Sidranksy D; Califano JA
    Arch Otolaryngol Head Neck Surg; 2009 May; 135(5):487-95. PubMed ID: 19451471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression profiling: decoding breast cancer.
    de Snoo F; Bender R; Glas A; Rutgers E
    Surg Oncol; 2009 Dec; 18(4):366-78. PubMed ID: 19879448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.